Neoplasms - Prevention & control
Research News and Information

Sunday, November 22, 2009

Protumor vs antitumor functions of IL-17.

29 Sep 2009 Inflammation appears to be a necessity for both metastasis and elimination of tumor cells. IL-17, a proinflammatory cytokine produced by Th17 cells, contributes to both the processes by playing a dual role in the antitumor immunity. On one hand, ... Read more...

Tumor immunology: new perspectives.

6 Sep 2009 This second meeting, organized by the Cancer Immunology Working Group of AACR, concentrated mainly on three areas of importance; these included (a) ways to increase the success rate of vaccination by improving the peptides themselves, improving ... Read more...

[Tumour illnesses and nutrition]

30 Aug 2009 It is very important for contemporary medicine to create new effective cytotoxic compounds of platinum with better clinical tolerance. Harmful elements which exist in food delivered to a human organism may either get inactive or activate complex ... Read more...

Latest indexed articles for 'Neoplasms - Prevention & control'

These are the very latest articles for this heading:

• Human papillomavirus vaccine for cancer prevention. 3 Nov 2009
• Cancer risk from extreme stressors: lessons from European Jewish survivors of World War II. 24 Oct 2009
• UK food agency reaffirms its advice that addition of folic acid to flour should be compulsory. 21 Oct 2009
• High-throughput screening finds potential killer of cancer stem cells. 12 Oct 2009
• Protumor vs antitumor functions of IL-17. 29 Sep 2009
• Uncontrolled HIV RNA, immunodeficiency, and malignancy: implications for cancer control. 29 Sep 2009
• [Vitamin D status and disease--hasty conclusions?] 22 Sep 2009
• A shot at cancer. 12 Sep 2009
• Tumor immunology: new perspectives. 6 Sep 2009
• [Tumour illnesses and nutrition] 30 Aug 2009
• Celebrities may help bring positive media attention to cancer. 30 Aug 2009
• [Cancer genetics: estimation of the needs of the population in France for the next ten years] 30 Aug 2009
• A safer stem cell: on guard against cancer. 30 Aug 2009
• Cancer risk assessment for the primary care physician. 30 Aug 2009
• Cancer control in low- and middle-income countries: the role of primary care physicians. 30 Aug 2009
• An overview of the cancer burden for primary care physicians. 30 Aug 2009
• Preface. Cancer: what the primary care practitioner needs to know, part I. 30 Aug 2009
• Foreword. Cancer: what the primary care practitioner needs to know, part I. 30 Aug 2009
• Should males be vaccinated against HPV? 30 Aug 2009
• Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening? 30 Aug 2009

See a longer list of these articles.

Technical information about 'Neoplasms'

Definition: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Descriptor UI: D009369

Alternative terms: Neoplasms; Neoplasm; Tumors; Tumor; Benign Neoplasms; Neoplasms, Benign; Benign Neoplasm; Neoplasm, Benign; Cancer; Cancers;

Related Mesh Headings: Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Carcinogens; DNA, Neoplasm; Oncogenic Viruses; Precancerous Conditions; RNA, Neoplasm; Pleural Effusion, Malignant; Genes, Tumor Suppressor; Anticarcinogenic Agents;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04;

Online Note: pre-explosion = NEOPLASMS (PX)

History Note: /diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977

Technical Notes: avoid: too general; prefer specifics; policy: Manual section 24; /chem ind permitted but consider also CARCINOGENS; /class: consider also NEOPLASM STAGING (see note there) but "grading" = /pathol; /etiol: consider also ONCOGENIC VIRUSES; /vet: Manual 24.6+ or TN 136; TN 135: MeSH terms for neoplasms classed by tissue; /drug ther: consider also ANTINEOPLASTIC AGENTS & its specifics; /genet: consider also GENES, TUMOR SUPPRESSOR /immunol: consider also TUMOR ESCAPE; consider also ANTIGENS, NEOPLASM & ANTIBODIES, NEOPLASM; /microbiol: consider also ONCOGENIC VIRUSES; /nurs = the patient, ONCOLOGIC NURSING = the oncologic specialty; /prev: consider also ANTICARCINOGENIC AGENTS; /radiother = the patient, RADIATION ONCOLOGY = the specialty; consider also BRACHYTHERAPY; /second = NEOPLASM METASTASIS but do not confuse with NEOPLASMS, SECOND PRIMARY; familial: consider also NEOPLASTIC SYNDROMES, HEREDITARY; metastatic cancer of unknown origin: index under NEOPLASM METASTASIS; Tumor Key: TN Suppl